Kayak Buys Rival SideStep for $200M

Related Newser Stories

• After Yahoo, Microsoft Amps Up Search Effort

  6 hours, 22 minutes ago
  CEO Steve Ballmer is spinning Microsoft’s failure to acquire Yahoo expertly, telling analysts today that, unburdened by the search giant, the company can be more frisky and adaptable in its fight with nemesis Google, the Wall Street Journal reports. Actions might speak louder than words, though: Microsoft announced yesterday it would give the leader of its online efforts the boot, and restructure. More »

• Hotel Porn Gets Spanking From Religious Right

  Jul 23, 08 9:20 PM CDT
  Conservatives are pressuring Marriott to remove adult films from its pay-per-view programming, saying porn doesn't jibe with the hotel chain's commitment to families, the St. Petersburg Times reports. "It's corporate greed,'' said the head of a Christian group. Marriott contends nixing the flicks isn't so easy: It owns only a few of the 3,000 properties operating under the brand. More »

• Tips for Frequent Fliers

  Jul 22, 08 8:45 PM CDT
  You sat in plenty of stuffy cabins to earn those frequent-flier miles: make sure you get a good trip out of them. Travel and Leisure runs down the best ways to earn miles and use them efficiently.
  
  

  1. Stick with one airline: The more you commit to a single airline, the better you'll be treated and the more miles you'll accumulate.
  2. Eat more, drive more: Rental car companies such as Hertz double the miles of some airline customers, and participating restaurants also offer such benefits.
  3. Ditch the mouse for the receiver: Booking a ticket by calling an airline agent can help you use your miles more efficiently than online booking.
  More »

• Roche Makes Genentech Takeover Bid

  Jul 21, 08 6:55 AM CDT
  Swiss pharmaceutical company Roche today offered $43.7 billion for the outstanding shares of Genentech, the San Francisco-based biotech firm in which Roche already owns a 55.9% stake, the Wall Street Journal reports. The $89-a-share offer is the latest in a series of big pharma companies, whose new drug development has been lagging, stepping up investment in the more productive biotech sector. More »

• Anheuser-Busch: The Deal That Sleeps With the Fishes

  Jul 17, 08 11:40 AM CDT
  Anyone mourning the takeover of Anheuser Busch by Belgium's InBev might want to know that the real turning point in that battle occurred more than a decade ago. On a fishing trip. In Mexico. The last real chance to outmaneuver InBev was lost when the US brewer failed to get a controlling stake in Mexico’s Grupo Modelo, writes David Kesmodel in the Wall Street Journal. And chances for that, say industry sources, vanished when former A-B CEO August Busch III decided to take a call instead of landing a humongous marlin. More »